7jgi
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ==NMR structure of the cNTnC-cTnI chimera bound to | + | ==NMR structure of the cNTnC-cTnI chimera bound to A7== |
| - | <StructureSection load='7jgi' size='340' side='right'caption='[[7jgi]]' scene=''> | + | <StructureSection load='7jgi' size='340' side='right'caption='[[7jgi]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full | + | <table><tr><td colspan='2'>[[7jgi]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7JGI OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=7JGI FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=7jgi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7jgi OCA], [http://pdbe.org/7jgi PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=7jgi RCSB], [http://www.ebi.ac.uk/pdbsum/7jgi PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=7jgi ProSAT]</span></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=V8Y:7-{[(5-chloronaphthalen-1-yl)sulfonyl]amino}heptanoic+acid'>V8Y</scene></td></tr> |
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">TNNI3, TNNC1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=7jgi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7jgi OCA], [http://pdbe.org/7jgi PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=7jgi RCSB], [http://www.ebi.ac.uk/pdbsum/7jgi PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=7jgi ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/TNNC1_HUMAN TNNC1_HUMAN]] Defects in TNNC1 are the cause of cardiomyopathy dilated type 1Z (CMD1Z) [MIM:[http://omim.org/entry/611879 611879]]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.<ref>PMID:15542288</ref> Defects in TNNC1 are the cause of familial hypertrophic cardiomyopathy type 13 (CMH13) [MIM:[http://omim.org/entry/613243 613243]]. A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.<ref>PMID:11385718</ref> <ref>PMID:16302972</ref> <ref>PMID:18572189</ref> <ref>PMID:19439414</ref> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/TNNC1_HUMAN TNNC1_HUMAN]] Troponin is the central regulatory protein of striated muscle contraction. Tn consists of three components: Tn-I which is the inhibitor of actomyosin ATPase, Tn-T which contains the binding site for tropomyosin and Tn-C. The binding of calcium to Tn-C abolishes the inhibitory action of Tn on actin filaments. | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Heart muscle contraction is regulated by calcium binding to cardiac troponin C. This induces troponin I (cTnI) switch region binding to the regulatory domain of troponin C (cNTnC), pulling the cTnI inhibitory region off actin and triggering muscle contraction. Small molecules targeting this cNTnC-cTnI interface have potential in the treatment of heart disease. Most of these have an aromatic core which binds to the hydrophobic core of cNTnC, and a polar and often charged 'tail'. The calmodulin antagonist W7 is unique in that it acts as calcium desensitizer. W7 binds to the interface of cNTnC and cTnI switch region and weakens cTnI binding, possibly by electrostatic repulsion between the positively charged terminal amino group of W7 and the positively charged RRVR144-147 region of cTnI. To evaluate the role of electrostatics, we synthesized A7, where the amino group of W7 was replaced with a carboxyl group. We determined the high-resolution solution NMR structure of A7 bound to a cNTnC-cTnI chimera. The structure shows that A7 does not change the overall conformation of the cNTnC-cTnI interface, and the naphthalene ring of A7 sits in the same hydrophobic pocket as that of W7, but the charged tail takes a different route to the surface of the complex, especially with respect to the position of the switch region of cTnI. We measured the affinities of A7 for cNTnC and the cNTnC-cTnI complex and that of the cTnI switch peptide for the cNTnC-A7 complex. We also compared the binding of W7 and A7 for two cNTnC-cTnI chimeras, differing in the presence or absence of the RRVR region of cTnI. A7 decreased the binding affinity of cTnI to cNTnC substantially less than W7 and bound more tightly to the more positively charged chimera. We tested the effects of W7 and A7 on the force-calcium relation of demembranated rat right ventricular trabeculae and demonstrated that A7 has a much weaker desensitization effect than W7. We also synthesized A6, which has one less methylene group on the hydrocarbon chain than A7. A6 did not affect binding of cTnI switch peptide nor change the calcium sensitivity of ventricular trabeculae. These results suggest that the negative inotropic effect of W7 may result from a combination of electrostatic repulsion and steric hindrance with cTnI. | ||
| + | |||
| + | The Role of Electrostatics in the Mechanism of Cardiac Thin Filament Based Sensitizers.,Cai F, Robertson IM, Kampourakis T, Klein BA, Sykes BD ACS Chem Biol. 2020 Aug 21;15(8):2289-2298. doi: 10.1021/acschembio.0c00519. Epub, 2020 Jul 22. PMID:32633482<ref>PMID:32633482</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 7jgi" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Cai F]] | + | [[Category: Cai, F]] |
| - | [[Category: Kampourakis T]] | + | [[Category: Kampourakis, T]] |
| - | [[Category: Klein | + | [[Category: Klein, B A]] |
| - | [[Category: Robertson | + | [[Category: Robertson, I M]] |
| - | [[Category: Sykes | + | [[Category: Sykes, B D]] |
| + | [[Category: Calcium binding protein]] | ||
| + | [[Category: Calcium modulator]] | ||
| + | [[Category: Cardiac troponin]] | ||
| + | [[Category: Ef hand]] | ||
| + | [[Category: Metal binding protein]] | ||
Revision as of 20:56, 28 October 2020
NMR structure of the cNTnC-cTnI chimera bound to A7
| |||||||||||
